Recon: Gilead’s long-acting HIV drug beats Truvada in late-stage trial; Biocon seeks partner for generic weight loss drugs in China
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States